Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Structure Stages Expanded $161 Million IPO for Novel Small Molecules

Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma

AnHeart to Use Guardant’s Assays for NSCLC Trials of ROS1 Inhibitor

NeuShen and UMass Partner To Develop Gene Therapy for ALS

Nervtex AI Device Approved in China to Diagnose Parkinson’s

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China